GDF15 and heart failure: Other studies like valsartan heart failure trial (Val-HeFT trial) indicated that higher GDF-15 levels are associated with many pathological processes and then linked to the severity and progression of heart failure (HF), including neurohormonal activation, inflammation, myocyte death, and renal dysfunctions.